Covered recipient · General Payments record
JACOB C COUGHLIN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,228.04
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $755.89 | 34 |
| Long term medical supply or device loan | $29.97 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $220.71 | 11 |
| ABBVIE INC. | $148.91 | 7 |
| EISAI INC. | $108.82 | 2 |
| Amgen Inc. | $67.42 | 4 |
| PFIZER INC. | $58.21 | 3 |
| DEXCOM, INC. | $32.42 | 1 |
| Abbott Laboratories | $29.97 | 1 |
| SANOFI-AVENTIS U.S. LLC | $25.13 | 1 |
| Exact Sciences Corporation | $23.27 | 1 |
| Merck Sharp & Dohme Corporation | $19.29 | 1 |
| Acerta Pharma LLC | $17.56 | 1 |
| Lilly USA, LLC | $17.47 | 1 |
| Cranial Technologies, Inc | $16.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $29.97 | 04/03/2024 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 1125407001 | CMS |
| ABBVIE INC. | $28.68 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106957569 | CMS |
| ABBVIE INC. | $8.55 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106957571 | CMS |
| ABBVIE INC. | $20.55 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106957573 | CMS |
| ABBVIE INC. | $27.56 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106957575 | CMS |
| ABBVIE INC. | $22.46 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106957577 | CMS |
| ABBVIE INC. | $28.03 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106957579 | CMS |
| ABBVIE INC. | $13.08 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106957581 | CMS |
| Amgen Inc. | $18.95 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115533073 | CMS |
| Amgen Inc. | $13.85 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115533082 | CMS |
| Amgen Inc. | $16.57 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117532442 | CMS |
| Amgen Inc. | $18.05 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115533092 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.56 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104688044 | CMS |
| Cranial Technologies, Inc | $16.68 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082243184 | CMS |
| Dexcom, Inc. | $32.42 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153363648 | CMS |
| Eisai Inc. | $88.11 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110803750 | CMS |
| Eisai Inc. | $20.71 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110803752 | CMS |
| Exact Sciences Corporation | $23.27 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114432626 | CMS |
| Lilly USA, LLC | $17.47 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135685491 | CMS |
| Merck Sharp & Dohme LLC | $19.29 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141968871 | CMS |
| Novo Nordisk Inc | $18.53 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100266154 | CMS |
| Novo Nordisk Inc | $23.56 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100393578 | CMS |
| Novo Nordisk Inc | $15.23 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100625912 | CMS |
| Novo Nordisk Inc | $20.60 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100482569 | CMS |
| Novo Nordisk Inc | $23.45 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100278418 | CMS |
| Novo Nordisk Inc | $14.93 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100251258 | CMS |
| Novo Nordisk Inc | $23.47 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100268994 | CMS |
| Novo Nordisk Inc | $21.43 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100284766 | CMS |
| Novo Nordisk Inc | $21.61 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100297429 | CMS |
| Novo Nordisk Inc | $21.79 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100239384 | CMS |
| Novo Nordisk Inc | $16.11 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100324414 | CMS |
| PFIZER INC. | $14.52 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131259899 | CMS |
| PFIZER INC. | $29.36 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131341989 | CMS |
| PFIZER INC. | $14.33 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131885807 | CMS |
| SANOFI-AVENTIS U.S. LLC | $25.13 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139863136 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.